☰

Access to antiretroviral drugs in low- and middle-income countries

This report examines global trends in ARV prices and assess how WHO treatment guidelines have influenced the uptake of different ARV formulations. It describes the current constraints limiting the use of second-line and third-line treatments and paediatric treatment, and it explores how the quality of ARVs can be secured and in-country distribution can be improved.

Approvisionnement, Assurance Qualité, Fixation des prix, Gestion, Politique, Usage

  • Sous-catégories VIH/SIDA
  • Commodities Médicaments
  • Date de mise à jour July 2014
  • Version July 2014
  • Développé par WHO
  • Quand l'utiliser This report examines global trends in ARV prices and assess how WHO treatment guidelines have influenced the uptake of different ARV formulations. It describes the current constraints limiting the use of second-line and third-line treatments and paediatric treatment, and it explores how the quality of ARVs can be secured and in-country distribution can be improved.
  • Langues Anglais
  • Niveau d'utilisation Central
  • Forme pdf file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Coût free
  • Advantages n/a
  • Contraintes n/a
  • Disponibilité http://apps.who.int/iris/bitstream/10665/128150/1/9789241507547_eng.pdf?ua=1
  • Remarques
  • Contact amds@who.int (HIV/AIDS Department, World Health Organization)
  • Submission date 2014-07-28 14:22:27